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iew. Total antibodies to hepatitis A virus were detected
y EIA. Frequencies of HAV infection by region and the
ge distribution of the susceptible population were esti-
ated and odds ratio (95% CI) were calculated using
LLAMM.
Results: The prevalence of hepatitis A infection in the
—9 and 10—19 age-group by region: North (28.7% and
7.5%); Northeast (41.5% and 57.4%); Midwest (32.3 and
6.0%); Federal District (33.8% and 65.1%); Southeast (20.6%
nd 37.7%); South (18.9% and 34.5%). There was increasing
rend for the prevalence of HAV infection with age in all
ites. The curves of susceptible populations differed from
ne area to another. Multilevel modelling showed that depri-
ation/low socio-economic status was associated with HAV
nfection in all regions.
Conclusion: This is the ﬁrst national population-based
urvey to determine prevalence of hepatitis A (HBA) in
ll capital cities showing the shift pattern from high to
ntermediated/ low endemicity. Differences in age trends
f infection were detected among settings. This multilevel
odel allowed for quantiﬁcation of contextual predictors of
epatitis A infection in urban areas. Support: PAHO, Ministry
f Health, CNPq.
oi:10.1016/j.ijid.2010.02.2017
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cute liver failure in the Colombian pediatric population:
etrospective and prospective studies
. Santamaria1,∗, M.M. contreras2, L.C. Rubiano3, R.
evivero4, F. Medina5, J. Mojica6
Hospital Universitario San Vicente de Paul, MEDELLIN,
olombia
Hospital General De Medellin, Medellin, Antioquia, Colom-
ia
3Health Public Department, Cali, Valle Del Cauca, Colom-
ia
Hospital Infantil Napoleon Franco Pareja, Cartagena,
olombia
Clinic san luis, bucaramanga, Colombia
Sanoﬁ Pasteur Colombia, Bogota, Colombia
Background: Describe the epidemiological and clinical
haracteristics in the pediatric patients with Acute Liver
ailure that were attended in the period between 1998 and
009 in the different health institutions in Colombia.
Methods: A transversal study based on the revision of
linical histories and questionnaires carried out in 10 health
nstitutions in 5 Colombian cities; including 2 Centers spe-
ialized in Transplants to evaluate the cases of Fulminant
epatic Failure in patients under the age of 18 years of age
resented between January 1998 and November 2009. FHF
as deﬁned as: 1). The elevation of AST and ALT aminotrans-
erases and/or the elevation of conjugated bilirubin. 2). The
bsence of known chronic hepatic disease. 3). INR > or equal
o 1.5 or PT > or equal to 15 seconds after the administration
f vitamin K, if the patient presents encephalopathy or 4).
n INR > or equal to 2.0 or TP > or equal to 20 seconds after
he administration of vitamin K if encephalopathy is not
resented. 5.) The degree of encephalopathy was stratiﬁed
ccording to age and according to its classiﬁcation.ternational Congress on Infectious Diseases (ICID) Abstracts
Results: 47 clinical histories were revised and 46 sub-
ects were included. The average age was 5.8 years of age
4 months of age — 16 years of age); of which 58.6% corre-
ponded to the female gender; 28.35% (13/46) coming from
ural areas. Jaundice was found in 100% of the subjects upon
ntry and encephalopathy in 76% (35/46). Liver failure was
ortal in 32.6% (15/46), with the average age being 6, 5
ears of age. Infection as a result of the Hepatitis A Virus
as one of the ﬁrst causes of FHF with 32.6% (15/46) as well
s Indeterminate Hepatitis (32.6%) and 15.2% caused by a
oxic reaction to the medications. The greatest proportion
f deaths is associated to Indeterminate Hepatitis due to
he forcefulness of the disease and the limited elements to
nderstand its etiology. 76.6% of the transplant candidates
btained a successful transplant (67%); retransplant was car-
ied out in 2 subjects, one died and the other managed to
urvive.
Conclusion: Acute Liver Failure is a frequent pathology
mong the pediatric ages in Colombia and is caused by the
epatitis A Virus in up to 32.6% of the cases. A high per-
entage of patients need liver transplantation and in some
ases have fatal consequences. Many of these cases are pre-
entable with vaccination.
oi:10.1016/j.ijid.2010.02.2018
3.037
epatitis B seroprevalence and associated factors in preg-
ant women and their couples in 6 Amazonian indigenous
opulations in Peru 2007—2008
. Ormaeche ∗, A. Whittembury, L. Suarez-Ognio, M. Pun
Ministry of Health from Peru, Lima, Peru
Background: Since 1995, there are reports documenting
igh magnitude of Hepatitis B transmission, but information
bout associated factors is scarce.
Methods: From June 2007 to december 2008 a sero-
revalence study was conducted in 6 Amazonian indigenous
opulations: Shispibo-Konibo, Ashaninka, Kandozi, Shapra,
hayahuita, Matsigenka. Objective: to determine the mag-
itude of Hepatitis B infection, and associated factors.
lood samples and written surveys were obtained. Informed
onsent was obtained from National, Regional and local
ommunity leaders and participants. For Hepatitis B testing,
BsAg and Anti-HBc elisa tests were performed.
Results: 1274 pregnant women and 721 male cou-
les were surveyed. Anti-HBc positive results: 522 women
42.06% [95%CI: 39.30% — 44.87%]) and 377 males
54.09% [IC95%CI: 50.31%—57.84%]). HBsAg were positive for
1/393 Anti-HBc positive women (2.80% [IC95%: 1.41% —
.95%]), and 15/312 Anti-HBc positive males (4.81% [IC95%:
.72%—7.81%]).
Anti-HBc positivity in women was associated to:
tracts e239
OR (95%CI) P value
7.15 (5.09—10.03) 0.000
0.75 (0.59—0.96) 0.013
5.49 (2.38—12.64) 0.000
0.54 (0.40—0.72) 0.000
1.32 (1.05—1.66) 0.008
1.94 (1.36—2.76) 0.000
1.65 (1.22—2.23) 0.000
1.90 (1.22—2.96) 0.002
OR (95%CI) P value
5.88 (2.26—15.28) 0.000
0.41 (0.18—0.88) 0.016
1.99 (1.38—2.89) 0.000
1.60 (1.09—2.36) 0.010
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diagnosis of and surveillance for hepatitis E would require
the use of anti-HEV IgM assays with the better performance
characteristics.
doi:10.1016/j.ijid.2010.02.202014th International Congress on Infectious Diseases (ICID) Abs
Associated factor
Male couple Anti-HBc positivity
Sex during menstruation
Male couple history of sex with other men
Being younger than 19 years
Sexual initiation before age 15 years
Male couple with more than 10 sex partners lifetime
Male couple with at least 1 more sex partner in last 12 months
Male couple with more than 20 sex partners lifetime
Anti-HBc positivity in men was associated to:
Associated factor
History of sex with other men lifetime
Being younger than 19 years
Sexual initiation before age 15 years
Having sex with women presenting vaginal secretion
Conclusion: Hepatitis B is hyperendemic in Amazonian
indigenous populations studied. These results suggest sex-
ual transmission as the main infection route of Hepatitis B in
indigenous population in reproductive age. A national plan of
Hepatitis B prevention and control in the Amazonian indige-
nous population in Peru is urgently needed to provide proper
education, vaccination and treatment.
doi:10.1016/j.ijid.2010.02.2019
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Performance of serologic assays speciﬁc to IgM antibodies
against hepatitis E virus: pangenotypic evaluation
J. Drobeniuc1,∗, J. Meng1, G. Reuter2, N. Khudyakov1, N.-T.
Le1, T. Greene-Montfort1, Z. Dimitrova1, S. Kamili 1, C.-G.
Teo1
1 Centers for Disease Control and Prevention, Atlanta, GA,
USA
2 Regional Laboratory of Virology, ANTSZ Regional Institute
of State Public Health Service, Pecs, Hungary
Background: The routine use of a reliable assay to iden-
tify infection by hepatitis E virus (HEV) belonging to all
4 genotypes is desirable in clinical practice and disease
surveillance. We evaluated assays developed to detect anti-
HEV IgM by interrogating them with panels of specimens
derived from patients known to be infected with HEV belong-
ing to each speciﬁc genotype.
Methods: Two in-house assays (assigned I and II) and
4 commercial assays (III to VI) were evaluated. Assay I
used as antigen a 56-kD protein expressed from open
reading frame (ORF) 2 of the SAR55 HEV strain in a bac-
ulovirus system. Assay II used as antigens recombinant
proteins (each 166 amino acids in length) derived from
ORF2 of 4 HEV strains, each strain originating from apeciﬁc genotype. The commercial assays evaluated were
urchased from International Immuno-Diagnostics (USA),
P-Diagnostics (Singapore), Diagnostic Systems (Russia) and
ikrogen Diagnostik (Germany). All 6 assays were of indirect
sandwich) format. A total of 194 sera comprised the test
anels. The acute hepatitis E panel comprised 51 samples
15 from patients infected by HEV belonging to genotype
, 4 to genotype 2, 15 to genotype 3 and 17 to genotype
). The non-acute hepatitis E panel comprised 143 sam-
les originating from patients with acute hepatitis A, acute
epatitis B and acute hepatitis C, as well as those conva-
escing from acute hepatitis E. Sensitivity, speciﬁcity and
nter-assay agreement were determined.
Results: The sensitivity of the assays among patients
nfected with 4 HEV genotypes varied from 72% for Assay IV
o 98% for Assays I, II and V. The speciﬁcity ranged between
5% for Assay I and 92% for Assays V and VI. Kappa values for
nter-assay agreement ranged from 0.38 to 0.75.
Conclusion: The sensitivities and speciﬁcities of the 6
nti-HEV IgM assays varied substantially. Inter-assay agree-
ents were mostly poor. Precise and accurate laboratory
